Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Change in Accured Expenses (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Change in Accured Expenses for 5 consecutive years, with -$3.1 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 55.12% year-over-year to -$3.1 million; the TTM value through Mar 2026 reached $4.0 million, down 88.0%, while the annual FY2025 figure was $121000.0, 99.65% down from the prior year.
  • Change in Accured Expenses hit -$3.1 million in Q1 2026 for Phathom Pharmaceuticals, up from -$6.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $19.9 million in Q4 2024 and bottomed at -$11.3 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $2.3 million, with a median of $2.9 million recorded in 2023.
  • On a YoY basis, Change in Accured Expenses climbed as much as 3654.17% in 2023 and fell as far as 282675.0% in 2023.
  • Phathom Pharmaceuticals' Change in Accured Expenses stood at $168000.0 in 2022, then surged by 3654.17% to $6.3 million in 2023, then soared by 216.2% to $19.9 million in 2024, then tumbled by 132.14% to -$6.4 million in 2025, then soared by 51.26% to -$3.1 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$3.1 million, -$6.4 million, and $6.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.